Header Logo

Christopher Seder

Concepts (363)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
35
2022
550
9.010
Why?
Carcinoma, Non-Small-Cell Lung
15
2021
240
5.400
Why?
Pneumonectomy
20
2022
77
5.220
Why?
Thoracic Surgery
14
2022
26
4.850
Why?
Esophageal Neoplasms
8
2022
50
3.680
Why?
Databases, Factual
13
2021
350
2.270
Why?
Societies, Medical
11
2020
123
2.120
Why?
Adenocarcinoma
8
2018
140
2.060
Why?
Thoracic Surgical Procedures
5
2019
9
1.770
Why?
Neoplasm Staging
13
2021
368
1.690
Why?
Humans
74
2023
27157
1.520
Why?
Thoracic Wall
3
2016
12
1.380
Why?
Postoperative Complications
8
2022
928
1.370
Why?
Quality Improvement
4
2019
137
1.330
Why?
Thoracic Surgery, Video-Assisted
7
2021
22
1.130
Why?
Neoplasm Recurrence, Local
3
2017
217
1.090
Why?
Biomarkers, Tumor
7
2022
207
1.080
Why?
Lung
5
2022
168
1.030
Why?
Aged
33
2021
9084
1.030
Why?
Neoplasms, Multiple Primary
2
2015
40
0.960
Why?
Female
39
2022
15269
0.920
Why?
Male
41
2022
14821
0.890
Why?
Cardiac Surgical Procedures
2
2016
36
0.860
Why?
Laparoscopy
3
2022
188
0.820
Why?
Colonic Neoplasms
3
2017
56
0.820
Why?
Biology
1
2022
8
0.800
Why?
Robotics
2
2013
25
0.800
Why?
Phosphoproteins
1
2022
26
0.800
Why?
Carcinoma, Adenoid Cystic
1
2022
3
0.770
Why?
Middle Aged
28
2022
9031
0.770
Why?
Registries
2
2021
199
0.730
Why?
Retrospective Studies
18
2022
3546
0.730
Why?
Advisory Committees
2
2018
20
0.710
Why?
Robotic Surgical Procedures
1
2021
34
0.710
Why?
Surgical Oncology
1
2020
6
0.700
Why?
Checklist
1
2020
33
0.680
Why?
Lymphadenopathy
1
2020
1
0.670
Why?
Prognosis
9
2022
803
0.670
Why?
Combined Modality Therapy
5
2020
305
0.650
Why?
Gases
1
2019
5
0.640
Why?
Intubation, Gastrointestinal
2
2010
11
0.640
Why?
Catheter Ablation
1
2020
60
0.640
Why?
Hate
1
2019
2
0.640
Why?
Carcinoma, Squamous Cell
4
2019
172
0.640
Why?
Chest Tubes
1
2019
4
0.640
Why?
Inhibin-beta Subunits
2
2009
2
0.630
Why?
Thoracotomy
3
2021
30
0.630
Why?
Clostridium Infections
2
2009
24
0.620
Why?
Enteral Nutrition
2
2010
62
0.620
Why?
Aged, 80 and over
15
2018
4831
0.600
Why?
Diaphragm
1
2018
8
0.590
Why?
Heart Diseases
2
2016
62
0.590
Why?
Mucous Membrane
1
2018
29
0.580
Why?
Foreign-Body Migration
1
2018
19
0.580
Why?
Scoliosis
1
2018
35
0.560
Why?
Risk Assessment
5
2019
628
0.560
Why?
Prosthesis Failure
2
2018
520
0.560
Why?
Internationality
1
2017
20
0.560
Why?
Databases as Topic
1
2017
14
0.550
Why?
Adult
16
2018
7918
0.550
Why?
Nurse Practitioners
1
2017
36
0.540
Why?
Quality Assurance, Health Care
1
2017
31
0.540
Why?
Benchmarking
1
2017
33
0.540
Why?
Ribs
1
2016
15
0.510
Why?
Cardiology
1
2016
45
0.510
Why?
Metformin
1
2016
17
0.500
Why?
Hypoglycemic Agents
1
2016
37
0.500
Why?
Pulmonary Blastoma
1
2015
4
0.500
Why?
United States
9
2021
2066
0.500
Why?
Mediastinal Neoplasms
1
2015
10
0.500
Why?
Testicular Neoplasms
1
2015
19
0.490
Why?
Neoplasm Invasiveness
4
2018
93
0.490
Why?
Academic Medical Centers
1
2016
133
0.490
Why?
Solitary Pulmonary Nodule
1
2015
14
0.480
Why?
Lung Diseases, Fungal
1
2015
10
0.470
Why?
Mucormycosis
1
2015
8
0.470
Why?
Early Medical Intervention
1
2015
14
0.470
Why?
Quality of Health Care
1
2016
102
0.470
Why?
Treatment Outcome
13
2021
3525
0.460
Why?
Survival Rate
7
2021
344
0.450
Why?
Practice Guidelines as Topic
1
2016
261
0.440
Why?
Surgical Mesh
1
2014
24
0.440
Why?
Risk Adjustment
3
2020
10
0.440
Why?
Manubrium
1
2014
2
0.440
Why?
Replantation
1
2014
10
0.440
Why?
Clavicle
1
2014
13
0.440
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
245
0.440
Why?
Herniorrhaphy
1
2014
36
0.440
Why?
Diabetes Mellitus, Type 2
1
2016
165
0.430
Why?
Esophagectomy
3
2022
23
0.410
Why?
Tricuspid Valve Prolapse
1
2012
1
0.410
Why?
Mitral Valve Annuloplasty
1
2012
1
0.410
Why?
Prostheses and Implants
1
2014
154
0.400
Why?
Heart Valve Prosthesis Implantation
1
2012
25
0.390
Why?
Breast Neoplasms
2
2017
411
0.390
Why?
Surgery, Computer-Assisted
1
2012
51
0.390
Why?
Cell Line, Tumor
4
2022
264
0.370
Why?
Tomography, X-Ray Computed
6
2018
667
0.360
Why?
Spinal Fusion
1
2018
464
0.350
Why?
Survival Analysis
3
2018
261
0.350
Why?
Simulation Training
2
2021
39
0.350
Why?
Myxoma
1
2010
4
0.340
Why?
Mitral Valve
1
2010
9
0.340
Why?
Heart Neoplasms
1
2010
12
0.340
Why?
Neoadjuvant Therapy
3
2022
65
0.340
Why?
Energy Intake
1
2010
83
0.320
Why?
Aneurysm, Infected
1
2009
1
0.320
Why?
Clostridium septicum
1
2009
1
0.320
Why?
Aortitis
1
2009
2
0.320
Why?
Embolism
1
2009
3
0.320
Why?
Embolectomy
1
2009
3
0.320
Why?
Mesenteric Vascular Occlusion
1
2009
3
0.320
Why?
Blood Component Transfusion
1
2009
4
0.320
Why?
Jehovah's Witnesses
1
2009
3
0.320
Why?
Treatment Refusal
1
2009
11
0.320
Why?
Gene Expression Regulation, Neoplastic
2
2009
124
0.320
Why?
Aortic Aneurysm
1
2009
12
0.310
Why?
Ischemia
1
2009
24
0.310
Why?
Enterocolitis, Pseudomembranous
1
2009
12
0.310
Why?
Length of Stay
4
2016
319
0.310
Why?
Blood Vessel Prosthesis Implantation
3
2018
20
0.310
Why?
Religion and Medicine
1
2009
25
0.310
Why?
Intraoperative Complications
1
2009
66
0.310
Why?
Bronchoscopy
3
2019
33
0.300
Why?
Critical Care
1
2010
122
0.300
Why?
Internship and Residency
3
2018
215
0.300
Why?
Risk Factors
4
2022
2333
0.300
Why?
Epigenesis, Genetic
1
2009
84
0.300
Why?
Surgeons
2
2020
88
0.290
Why?
Hospital Costs
1
2008
60
0.290
Why?
Education, Medical, Graduate
2
2020
79
0.290
Why?
Sarcoma
2
2021
148
0.270
Why?
Intensive Care Units
1
2008
265
0.260
Why?
Trachea
2
2022
46
0.260
Why?
Disease-Free Survival
2
2017
179
0.260
Why?
Follow-Up Studies
5
2021
1802
0.260
Why?
Clinical Competence
3
2020
210
0.250
Why?
Early Detection of Cancer
4
2022
104
0.240
Why?
Neovascularization, Pathologic
2
2015
36
0.230
Why?
Biomarkers
2
2017
559
0.230
Why?
Surgical Flaps
2
2015
50
0.220
Why?
Chemoradiotherapy
2
2015
61
0.220
Why?
Embolism, Air
1
2023
10
0.220
Why?
Consensus
2
2021
92
0.210
Why?
Bronchi
2
2015
12
0.200
Why?
Thymoma
2
2020
7
0.200
Why?
Thrombosis
1
2023
54
0.200
Why?
Computer Simulation
2
2021
195
0.200
Why?
Blood Coagulation Disorders
1
2022
14
0.200
Why?
Thymus Neoplasms
2
2020
12
0.200
Why?
Hemostatics
1
2022
11
0.200
Why?
Carbon Monoxide
1
2022
6
0.200
Why?
Intubation, Intratracheal
2
2016
96
0.190
Why?
Lymph Nodes
2
2020
73
0.190
Why?
Metastasectomy
1
2021
6
0.190
Why?
Programmed Cell Death 1 Receptor
1
2022
18
0.190
Why?
Cohort Studies
4
2018
1901
0.190
Why?
Multivariate Analysis
3
2017
331
0.190
Why?
Ventricular Dysfunction, Right
1
2021
9
0.180
Why?
Patient Discharge
1
2022
151
0.180
Why?
Heart-Assist Devices
1
2021
19
0.180
Why?
Incidence
2
2021
763
0.180
Why?
Mediastinal Cyst
1
2020
1
0.170
Why?
Mass Screening
2
2022
173
0.170
Why?
RNA, Messenger
3
2009
310
0.160
Why?
Carcinoma
2
2017
68
0.160
Why?
Smoking
1
2020
183
0.160
Why?
Small Cell Lung Carcinoma
1
2019
7
0.160
Why?
Ultrasonography, Interventional
1
2020
71
0.160
Why?
Heart Failure
1
2021
149
0.160
Why?
False Positive Reactions
1
2019
34
0.160
Why?
Insulin-Like Growth Factor I
2
2022
59
0.160
Why?
Drainage
1
2019
44
0.150
Why?
Sensitivity and Specificity
4
2018
485
0.150
Why?
RNA, Small Interfering
2
2009
81
0.150
Why?
Unnecessary Procedures
1
2019
27
0.150
Why?
Kaplan-Meier Estimate
2
2009
177
0.150
Why?
Thoracoscopy
3
2019
22
0.150
Why?
Randomized Controlled Trials as Topic
1
2020
291
0.150
Why?
Obesity
1
2021
309
0.150
Why?
Aortic Aneurysm, Thoracic
1
2018
10
0.150
Why?
Cell Proliferation
2
2009
179
0.150
Why?
Histocompatibility Antigens Class II
1
2018
6
0.150
Why?
HLA Antigens
1
2018
14
0.150
Why?
Hemoptysis
1
2018
7
0.150
Why?
Histocompatibility Antigens Class I
1
2018
15
0.150
Why?
Multiple Pulmonary Nodules
1
2018
11
0.150
Why?
Syndecan-1
1
2018
5
0.150
Why?
Radiography, Thoracic
1
2018
27
0.150
Why?
Immunohistochemistry
2
2009
374
0.150
Why?
Chest Pain
1
2018
20
0.140
Why?
Diagnosis, Differential
2
2018
347
0.140
Why?
Morbidity
2
2019
54
0.140
Why?
Immunoassay
1
2018
38
0.140
Why?
Nerve Growth Factors
1
2018
38
0.140
Why?
Tracheomalacia
1
2017
4
0.140
Why?
Tracheal Stenosis
1
2017
6
0.140
Why?
Silicones
1
2017
11
0.140
Why?
Bronchial Neoplasms
1
2017
5
0.140
Why?
Airway Obstruction
1
2017
19
0.140
Why?
Suture Techniques
1
2018
156
0.140
Why?
Lymphoma
1
2017
36
0.140
Why?
History, 19th Century
1
2016
6
0.130
Why?
History, 21st Century
1
2016
20
0.130
Why?
History, 20th Century
1
2016
31
0.130
Why?
Diffusion of Innovation
1
2016
24
0.130
Why?
Stents
1
2017
81
0.130
Why?
Biopsy
1
2017
200
0.130
Why?
Melanoma
1
2017
58
0.130
Why?
Adolescent
1
2022
2179
0.130
Why?
Pulmonary Diffusing Capacity
1
2016
8
0.130
Why?
Pneumonia, Bacterial
1
2016
11
0.130
Why?
Europe
1
2016
57
0.130
Why?
Tracheostomy
1
2016
24
0.130
Why?
Minimally Invasive Surgical Procedures
2
2010
316
0.130
Why?
Prospective Studies
1
2021
1783
0.130
Why?
Etoposide
1
2015
27
0.120
Why?
Ifosfamide
1
2015
13
0.120
Why?
Models, Statistical
1
2016
127
0.120
Why?
Cisplatin
1
2015
61
0.120
Why?
Time Factors
1
2019
1438
0.120
Why?
Thymus Gland
1
2015
11
0.120
Why?
Proportional Hazards Models
1
2016
350
0.120
Why?
Diabetes Mellitus
1
2016
129
0.120
Why?
Insulin-Like Growth Factor II
1
2014
10
0.120
Why?
Insulin-Like Growth Factor Binding Proteins
1
2014
10
0.110
Why?
Comorbidity
1
2016
488
0.110
Why?
Thoracic Cavity
1
2014
1
0.110
Why?
Antineoplastic Agents
1
2016
202
0.110
Why?
Thoracic Neoplasms
1
2014
9
0.110
Why?
Chicago
1
2016
948
0.110
Why?
Mediastinum
1
2013
6
0.100
Why?
Hernia, Hiatal
1
2013
13
0.100
Why?
Fatal Outcome
2
2011
56
0.100
Why?
Tricuspid Valve Insufficiency
1
2012
2
0.100
Why?
Histone Acetyltransferases
2
2009
4
0.100
Why?
Acetylation
2
2009
14
0.100
Why?
Histone Deacetylases
2
2009
11
0.100
Why?
Dyspnea
1
2012
43
0.100
Why?
Oligonucleotide Array Sequence Analysis
2
2009
59
0.100
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2009
144
0.100
Why?
Age Factors
2
2016
775
0.090
Why?
Fistula
1
2011
2
0.090
Why?
Gastric Fistula
1
2011
5
0.090
Why?
Anastomotic Leak
1
2011
6
0.090
Why?
Lung Transplantation
1
2011
13
0.090
Why?
Living Donors
1
2011
17
0.090
Why?
Continuous Positive Airway Pressure
1
2011
23
0.090
Why?
Tissue and Organ Procurement
1
2011
35
0.090
Why?
Postoperative Hemorrhage
1
2011
25
0.090
Why?
Graft Rejection
1
2011
69
0.090
Why?
Sutures
1
2011
52
0.090
Why?
Endoleak
1
2010
1
0.090
Why?
Aortic Aneurysm, Abdominal
1
2010
4
0.090
Why?
Chordae Tendineae
1
2010
1
0.090
Why?
Blood Pressure Determination
1
2010
14
0.090
Why?
Blood Vessel Prosthesis
1
2010
13
0.090
Why?
Surgical Tape
1
2010
3
0.080
Why?
Monitoring, Intraoperative
1
2010
37
0.080
Why?
Conscious Sedation
1
2010
5
0.080
Why?
Glasgow Coma Scale
1
2010
8
0.080
Why?
APACHE
1
2010
27
0.080
Why?
Endovascular Procedures
1
2010
32
0.080
Why?
Equipment Failure
1
2010
39
0.080
Why?
Gastric Bypass
1
2011
69
0.080
Why?
Heart Ventricles
1
2010
88
0.080
Why?
Activins
1
2009
1
0.080
Why?
Follistatin
1
2009
1
0.080
Why?
Mesenteric Artery, Superior
1
2009
2
0.080
Why?
Probability
1
2009
86
0.080
Why?
Tissue Array Analysis
1
2009
8
0.080
Why?
Iliac Artery
1
2009
5
0.080
Why?
Statistics, Nonparametric
1
2009
119
0.080
Why?
Blood Pressure
1
2010
195
0.080
Why?
Multiple Organ Failure
1
2009
17
0.080
Why?
Aorta
1
2009
17
0.080
Why?
Digestive System Surgical Procedures
1
2009
24
0.080
Why?
Histones
1
2009
32
0.080
Why?
Cattle
1
2009
124
0.080
Why?
Transfection
1
2009
121
0.080
Why?
Blotting, Western
1
2009
148
0.080
Why?
Histone Deacetylase Inhibitors
1
2008
8
0.080
Why?
Promoter Regions, Genetic
1
2009
95
0.080
Why?
Safety
1
2008
37
0.080
Why?
Debridement
1
2009
100
0.080
Why?
Acute Disease
1
2009
177
0.080
Why?
Glycoproteins
1
2008
49
0.070
Why?
Cost-Benefit Analysis
1
2008
126
0.070
Why?
Enzyme Inhibitors
1
2008
117
0.070
Why?
Anticoagulants
1
2009
88
0.070
Why?
Recurrence
1
2009
309
0.070
Why?
Carrier Proteins
1
2008
98
0.070
Why?
Up-Regulation
1
2009
175
0.070
Why?
Autoantibodies
1
2008
82
0.070
Why?
DNA Methylation
1
2009
164
0.070
Why?
Anti-Bacterial Agents
1
2009
369
0.060
Why?
Magnetic Resonance Imaging
1
2010
1104
0.060
Why?
Reproducibility of Results
2
2019
673
0.060
Why?
Iatrogenic Disease
1
2023
25
0.050
Why?
Thrombelastography
1
2022
5
0.050
Why?
Blood Coagulation Tests
1
2022
12
0.050
Why?
Hemostasis
1
2022
11
0.050
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2022
5
0.050
Why?
Hemorrhage
1
2022
82
0.050
Why?
Tumor Microenvironment
1
2022
21
0.050
Why?
Inflammation
1
2023
274
0.050
Why?
Animals
1
2009
3625
0.050
Why?
Predictive Value of Tests
2
2014
478
0.050
Why?
Equipment Design
2
2011
136
0.040
Why?
Young Adult
2
2017
2026
0.040
Why?
Mediastinoscopy
1
2019
6
0.040
Why?
Hemolysis
1
2018
5
0.040
Why?
North America
1
2018
39
0.040
Why?
Canada
1
2018
46
0.040
Why?
Magnetic Resonance Angiography
1
2018
31
0.040
Why?
Pneumonia
1
2019
68
0.040
Why?
Carcinoma, Embryonal
1
2017
2
0.030
Why?
Dilatation
1
2017
10
0.030
Why?
Tonsillar Neoplasms
1
2017
3
0.030
Why?
Leiomyosarcoma
1
2017
23
0.030
Why?
Carcinoma, Renal Cell
1
2017
47
0.030
Why?
Propensity Score
1
2016
36
0.030
Why?
Kidney Neoplasms
1
2017
79
0.030
Why?
Skin Neoplasms
1
2017
79
0.030
Why?
Neoplasm, Residual
1
2015
6
0.030
Why?
Practice Patterns, Physicians'
1
2016
110
0.030
Why?
Lymph Node Excision
1
2015
27
0.030
Why?
Chemoradiotherapy, Adjuvant
1
2015
17
0.030
Why?
Radiotherapy Dosage
1
2015
100
0.030
Why?
Minnesota
1
2014
6
0.030
Why?
Sex Factors
1
2016
466
0.030
Why?
Analysis of Variance
1
2015
256
0.030
Why?
Postoperative Period
1
2016
334
0.030
Why?
Area Under Curve
1
2014
64
0.030
Why?
ROC Curve
1
2014
141
0.030
Why?
Patient Readmission
1
2015
130
0.030
Why?
Illinois
1
2014
250
0.030
Why?
Cytokines
1
2014
233
0.030
Why?
Algorithms
1
2014
352
0.020
Why?
Disease Progression
1
2014
672
0.020
Why?
Hematemesis
1
2011
2
0.020
Why?
Stomach Ulcer
1
2011
4
0.020
Why?
Proton Pump Inhibitors
1
2011
11
0.020
Why?
Esophageal Perforation
1
2011
8
0.020
Why?
Gastrointestinal Hemorrhage
1
2011
23
0.020
Why?
Candidiasis
1
2011
24
0.020
Why?
Pulmonary Gas Exchange
1
2011
6
0.020
Why?
Surgical Stapling
1
2011
5
0.020
Why?
Constriction, Pathologic
1
2011
32
0.020
Why?
Graft Survival
1
2011
97
0.020
Why?
Transducers, Pressure
1
2010
4
0.020
Why?
Aortography
1
2010
6
0.020
Why?
Respiration, Artificial
1
2011
109
0.020
Why?
Rupture
1
2010
109
0.020
Why?
Obesity, Morbid
1
2011
105
0.020
Why?
Hydroxamic Acids
1
2008
5
0.020
Why?
Immunoenzyme Techniques
1
2008
31
0.020
Why?
Adipokines
1
2008
7
0.020
Why?
Azacitidine
1
2008
11
0.020
Why?
Tumor Cells, Cultured
1
2008
129
0.020
Why?
Gene Expression Profiling
1
2008
143
0.020
Why?
Reoperation
1
2011
921
0.020
Why?
Case-Control Studies
1
2008
589
0.020
Why?
Seder's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (363)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_